The latest closing stock price for Bone Biologics as of September 18, 2024 is 2.08.
An investor who bought $1,000 worth of Bone Biologics stock at the IPO in 2021 would have $-998 today, roughly -1 times their original investment - a -88.06% compound annual growth rate over 3 years.
The all-time high Bone Biologics stock closing price was 1315.20 on November 01, 2021.
The Bone Biologics 52-week high stock price is 10.56, which is 407.7% above the current share price.
The Bone Biologics 52-week low stock price is 0.80, which is 61.5% below the current share price.
The average Bone Biologics stock price for the last 52 weeks is 2.74.
An investor who bought $1,000 worth of Bone Biologics stock at the IPO in 2021 would have $-998 today, roughly -1 times their original investment - a -88.06% compound annual growth rate over 3 years.
The all-time high Bone Biologics stock closing price was 1315.20 on November 01, 2021.
The Bone Biologics 52-week high stock price is 10.56, which is 407.7% above the current share price.
The Bone Biologics 52-week low stock price is 0.80, which is 61.5% below the current share price.
The average Bone Biologics stock price for the last 52 weeks is 2.74.